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Acute pain triggers adaptive physiological responses that serve as protective mecha-
nisms that prevent continuing damage to tissues and cause the individual to react to 
remove or escape the painful stimulus. However, an extension of the pain response 
beyond signaling tissue damage and healing, such as in chronic pain states, serves 
no particular biological function; it is maladaptive. The increasing number of chronic 
pain sufferers is concerning, and the associated disease burden is putting healthcare 
systems around the world under significant pressure. The incapacitating effects of 
long-lasting pain are not just psychological – reflexes driven by nociceptors during the 
establishment of chronic pain may cause serious physiological consequences on regu-
lation of other body systems. The sympathetic nervous system is inherently involved in a 
host of physiological responses evoked by noxious stimulation. Experimental animal and 
human models demonstrate a diverse array of heterogeneous reactions to nociception. 
The purpose of this review is to understand how pain affects the sympathetic nervous 
system by investigating the reflex cardiovascular and neural responses to acute pain and 
the long-lasting physiological responses to prolonged (tonic) pain. By observing the sym-
pathetic responses to long-lasting pain, we can begin to understand the physiological 
consequences of long-term pain on cardiovascular regulation.
Keywords: blood pressure, cutaneous pain, muscle pain, nociception, muscle sympathetic nerve activity, skin 
sympathetic nerve activity
iNTRODUCTiON
Pain serves a purpose. In normal physiology, it acts as a protective mechanism to prevent damage to 
tissues and causes the individual to react to remove or escape the painful stimulus (1). The sensory 
experience of pain has been described as “the psychical adjunct of a protective reflex” (2, 3). As pain is 
characteristically unpleasant, while other sensations are affectively neutral, the concept of sensation 
does not seem to encompass the experience of pain [Ref. (4) cited in Ref. (5)]. A more holistic 
approach to pain in humans is that of a homeostatic emotion reflecting an adverse condition in the 
body that requires a behavioral response (6). A direct offshoot of this behaviorist school of thought is 
that of adaptive behavioral responses to pain originating in different tissues: “… noxious stimulation 
produces arousal, orientation, escape or immobilisation and help-seeking. Each of these is a behaviour 
that reflects a motivational demand” (5).
While this homeostatic mechanism is crucial in maintaining the physiological integrity of the 
animal, an extension of the pain response beyond signaling tissue damage and healing, such as in 
chronic pain states, is of greater concern. The increasing number of chronic pain sufferers and the 
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associated disease burden is putting healthcare systems around 
the world under significant pressure. Current research efforts are 
targeted toward understanding the mechanism behind the devel-
opment of chronic pain and the transition from acute to chronic 
pain. It is widely accepted that chronic pain is established follow-
ing activation of nociceptors in the initial stages, but can perpetu-
ate to an ongoing experience of pain in the absence of ongoing 
noxious input. According to a recent position statement “chronic 
pain may occur due to the persistent stimulation of nociceptors in 
areas of ongoing tissue…[but]… chronic pain persists long after 
the tissue damage that initially triggered its onset has resolved, and 
in some individuals, chronic pain can continue without ongoing 
tissue damage or preceding injury that can be detected with cur-
rently available diagnostic technology” (7). Chronic pain is being 
increasingly recognized as a disease entity per  se, rather than 
simply a symptom (8). The incapacitating effects of long-lasting 
pain are not just psychological – reflexes driven by nociceptors 
during the establishment of chronic pain may cause serious 
physiological consequences. Knowledge of these processes is 
crucial not just for devising complex future pain treatment 
approaches but also for preventing pain from becoming chronic, 
since nociceptive reflexes – through their actions on peripheral 
tissues via, for example, the sympathetic nervous system – may 
exacerbate ongoing pain.
The sympathetic nervous system is inherently involved in a 
host of physiological responses evoked by noxious stimulation. 
These include changes in blood flow to muscle and skin, as well 
as changes in blood pressure (BP), heart rate (HR), sweat release, 
and pupil diameter. Of these “fight or flight” responses, only HR 
and pupil diameter may include changes in parasympathetic 
outflow; the remainder are subserved by changes in sympathetic 
outflow exclusively (1). While the immediate, reflexly driven, 
physiological responses to acute pain are purposeful, teleological 
explanations for the prolongation of these responses in chronic 
pain are more obscure. Thus, understanding the physiological 
changes associated with long-lasting pain becomes important 
in understanding the transition from acute to chronic pain. 
It is plausible that the physiological reflexes seen in acute pain 
are also observed in chronic pain states, but also possible that 
reflexogenic changes are replaced by maladaptive physiological 
changes. The purpose of this review is to understand how pain 
affects the sympathetic nervous system by investigating the reflex 
cardiovascular and neural responses to acute pain and the long-
lasting physiological responses to prolonged (tonic) pain.
ANiMAL STUDieS
The comprehensive studies by Jänig and colleagues, in which 
recordings were made from individual type-identified post-
ganglionic sympathetic axons in the cat, have shown that 
noxious stimuli are capable of producing a differential response 
from cutaneous and muscle sympathetic neurones. Noxious 
stimulation of skin with mechanically damaging and thermal 
stimuli caused excitation in a small number of skin sympathetic 
neurones in the anesthetized cat; however, these responses were 
an exception to the rule and the majority of these neurones were 
inhibited by cutaneous noxious stimulation (9). Overall, most 
muscle vasoconstrictor neurones were excited during noxious 
stimulation of skin. This occurred in both anesthetized (9) and 
spinalized cats (10), thus suggesting the involvement of a spinal 
reflex: “…the reflex pattern in muscular sympathetic fibres is the 
same on the spinal and on the brain stem level” (11).
Sato and colleagues found that while rotation of the knee 
joint within the normal physiological working range did not 
produce any autonomic effects in anesthetized cats, the same 
movements caused increases in BP and HR when the knee joint 
was experimentally inflamed (12). Furthermore, they found that 
noxious rotation of knee joints (deep pain) caused an increase 
in BP and HR in both control and inflamed knee joints – with 
greater increases in BP and HR being seen with rotation of the 
inflamed joint. Given the increases in HR in response to torsion 
of inflamed knee joints seen in the Sato et al. (12) study were 
quite modest (8 ± 4 beats/min), and while they did not directly 
measure muscle sympathetic nerve activity (MSNA)  –  bursts 
of which cause vasoconstriction in muscle vascular beds and 
thereby increase total peripheral resistance – it may be inferred 
that the reported increases in BP were caused by increases in 
MSNA (and possibly splanchnic sympathetic nerve activity). 
Furthermore, it has also been shown that painful electrical 
stimulation produces excitatory effects upon the autonomic 
nervous system. Sciatic nerve stimulation, at intensities that 
activate A-delta (Group III) afferent fibers, is capable of causing 
increases in BP and HR in spontaneously hypertensive rats (13). 
Overall, this body of evidence demonstrates that nociception is 
capable of exerting excitatory effects on sympathetic outflow 
to muscle.
Some nociceptors are chemoreceptors sensitive to the concen-
tration of irritant chemicals released into surrounding tissue by 
noxious thermal or mechanical stimuli, or reactive to exogenous 
chemicals that may penetrate the skin and bind to their sensory 
endings (14). Electrophysiological studies in experimental animals 
have shown that unmyelinated (group IV) and small-diameter 
(group III) nerve fibers in muscle respond both to the contraction 
and to the metabolic products of contraction (15–17). Moreover, 
activity in these afferents can be maintained by preventing release 
of the metabolic products; accordingly, these afferents are known as 
metaboreceptors (or ergoreceptors). Furthermore, lesion studies 
demonstrated that the reflex increase in sympathetically mediated 
vasoconstriction – the metaboreflex – requires the medulla (18); 
indeed, a somatosympathetic reflex can be demonstrated in the 
isolated brainstem–heart preparation (19). Electrophysiological 
evidence has revealed that group III and IV muscle afferents 
project to neurones in the rostral ventrolateral medulla (RVLM), 
the primary output nucleus for muscle vasoconstrictor drive (20), 
via the nucleus tractus solitarius and caudal ventrolateral medulla 
(CVLM) (21). Anatomically, it is expected that sustained noxious 
stimulation of muscle metaboreceptors can cause a supraspinally 
mediated increase in MSNA.
ADAPTive BeHAviORAL ReSPONSeS 
TO PAiN iN ANiMALS
In contrast to some of the aforementioned studies by Sato 
and colleagues, which suggest that noxious stimuli exert 
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excitatory effects upon the sympathetic nervous system, it has 
been reported that pain originating in deep structures such as 
joints, muscle, and viscera may evoke profound decreases in 
BP and HR in rats (22). Keay and colleagues hypothesize that 
these different cardiovascular responses are components of an 
integrated response aimed at dealing effectively with the noxious 
stimulus. Stimulation of discrete parts of the brain supports this 
theory. Activation of a specific region within the midbrain, the 
lateral periaqueductal gray matter (lPAG), evokes an integrated 
response similar to that evoked by cutaneous pain  –  that is, 
an excitatory flight/fight response characterized by increases 
in BP and HR (23). Conversely, activation of the ventrolateral 
periaqueductal gray matter (vlPAG) evokes a response similar to 
that evoked by deep pain – a conservative/withdrawal response 
characterized by a decrease in BP and HR (24). This concept is 
further supported by studies demonstrating that cutaneous pain 
preferentially activates the lPAG, whereas deep pain (induced by 
intramuscular injection of 5% formalin solution) preferentially 
activates the vlPAG (25). These data suggest that the tissue from 
which pain originates may have a significant influence on both 
the behavioral and cardiovascular responses, and may be an 
additional factor to consider.
HUMAN STUDieS
Approximately half a century ago, Sir Thomas Lewis observed that 
pain originating in deep structures evoked very different behavio-
ral and cardiovascular responses to pain originating in superficial 
structures (26). He observed that while pain originating in skin 
evoked “a rise of pulse rate” and a “sense of invigoration,” pain 
originating in deep structures evoked quiescence, a “slowing of 
the pulse” and “falling of the blood pressure.” Follow-up studies a 
decade later confirmed Lewis’ findings, where muscle pain was 
associated with a fall in BP and HR in awake human subjects 
(27). Interestingly, it appeared that a half-century hiatus passed 
without any further work being carried out in human subjects 
to determine whether pain originating in deep and superficial 
tissues produced differential effects on sympathetic activity until 
our group published in this area in 2009 (28, 29). Our lab has con-
tinued to explore the relationship between pain and sympathetic 
nervous system, shifting our focus from examining the effects of 
acute pain to that of tonic pain using a validated experimental 
model of pain.
For some time, the sympathetic nervous system has been 
considered to be involved in the chronic pain states formerly 
known as reflex sympathetic dystrophies (RSD), now labeled 
complex regional pain syndromes (CRPS). Subjects with CRPS 
often complain of a burning spontaneous pain in the distal part 
of the affected extremity. Presumed sympathetically mediated 
effects may cause the affected limb to be warm or cold; there 
may also be trophic changes (the skin wet or dry) and motor 
changes (30). There is evidence from human clinical studies 
supporting the idea that nociceptors develop catecholamine 
sensitivity after complete or partial nerve lesions; indeed, intra-
operative stimulation of the sympathetic chain has been shown 
to induce increases of spontaneous pain in some patients with 
CRPS (30).
However, intraneural recordings of sympathetic nerve activity 
in human subjects have found no differences in sympathetic out-
flow to a painful limb compared to the contralateral non-painful 
limb, either in patients with CRPS suspected to be sympatheti-
cally maintained (31) or in healthy subjects suffering a unilateral 
experimental painful stimulus (32). Even if no regional change 
in sympathetic outflow to a painful limb has been demonstrated 
in man, it is feasible that physiological variations in sympathetic 
discharge may modulate nociceptive transmission, as suggested 
by studies on CRPS patients reporting augmented pain follow-
ing the sympathoexcitation caused by arousal, forehead cooling 
(33), or whole-body cooling (34). Again, intraneural recording 
studies have not shown any relationship between the degree of 
sympathetic discharge and the level of perceived pain in CRPS 
patients (31, 35). While these studies have examined the effects of 
sympathetic activity in pathophysiological pain states – with the 
exception of our laboratory, relatively few groups have conducted 
intraneural sympathetic recordings in awake healthy human 
subjects using hypertonic saline to induce experimental muscle 
and skin pain, which better mimics clinical pain presentations.
Therefore, while the effects of short-lasting nociception on 
sympathetic outflow have been sufficiently investigated in a vari-
ety of both animal and human studies, the effects of long-lasting 
noxious stimulation on the regulation of sympathetic activity in 
humans are less understood. Indeed, undertaking such investiga-
tions may be more significant and relevant to understanding the 
role of the sympathetic nervous system in chronic pain states in 
humans. In order to examine the effects of tonic, long-lasting 
muscle pain on sympathetic outflow to skin and muscle, our group 
have used hypertonic saline and infused the solution through an 
intramuscular cannula over a 45-min period, which resulted in 
pain lasting for ~60 min (36–38).
eXPeRiMeNTAL PAiN AND 
MiCRONeUROGRAPHiC 
STUDieS iN HUMANS
Muscle Sympathetic Nerve Activity
Direct neural recordings from awake human subjects have dem-
onstrated increases in MSNA and BP in response to various forms 
of noxious stimulation, such as instillation of soap solution in the 
eye, strong mechanical pressure on the nail (39), immersion of a 
hand in ice water (40), and mechanical pressure on the skin (41). 
The problem with these stimuli is that they are not very selective 
in terms of the source of noxious stimulation, with mechanical 
pressure on the nail and immersion of the hand in ice-cold water 
stimulating many types of tissue. Increases in MSNA can also be 
induced by pain associated with spontaneous or evoked cluster 
headaches, which likely have a vascular origin (42). Cutaneous 
noxious inputs have shown consistent results in animal studies, 
with the consensus being an increase in MSNA. Interestingly 
in humans, while the majority of painful stimuli can produce 
increases in MSNA, painful electrical stimulation to the skin 
causes a short-lasting decrease in MSNA (43, 44). Earlier studies 
by our group found that the effects of acute noxious stimulation of 
skin in awake human subjects, induced by subcutaneous injection 
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of a bolus (0.2 ml) of hypertonic saline, mirror those found in 
studies in anesthetized animals  –  an increase in MSNA (28). 
Hypertonic saline specifically causes depolarization of C-fibers in 
the volume of tissue in which it is injected, allowing one to target 
a particular tissue and, hence, type of pain (45). Intramuscular 
injections qualitatively evoke a pain described as dull, diffuse, 
and poorly localized. By contrast, the quality of skin pain differs 
significantly and can be described as hot, sharp, burning, and 
clearly localized to a small area surrounding the injection site (28, 
29, 45). Considerable use of the hypertonic saline model has been 
employed to characterize the sensory and motor effects involved 
in muscle pain. This is largely due to the quality of the induced 
pain being comparable to acute clinical muscle pain possessing 
both localized and referred pain characteristics (45).
In contrast to cutaneous noxious stimulation, the effects of 
deep muscular pain on MSNA have shown more diverse results 
in the literature. In agreement with the results of animal studies 
by Sato et al. (12), we found that – in most cases – deep short-
lasting pain, induced by bolus (0.5 ml) intramuscular injection of 
hypertonic saline, generally caused an increase in MSNA in awake 
subjects (28). Indeed, these increases in MSNA – regardless of the 
source of noxious input (muscle or skin) – were associated with 
increases in BP and, as evidenced by the increase in HR, likely an 
increase in cardiac sympathetic drive. However, it must be noted 
that a minority of subjects displayed the inverse: a reduction in 
MSNA in response to short-lasting acute pain (28). Importantly, 
we also showed that the sympathetic responses to noxious 
stimulation of either muscle or skin depended on the integrity of 
supraspinal projections: intramuscular or subcutaneous injection 
of hypertonic saline into the paralyzed legs of individuals with 
spinal cord injury, who could not feel the pain, failed to gener-
ate any autonomic markers that would have indicated a spinal 
reflex; in other words, in awake human subjects, the sympathetic 
responses to pain are psychogenic (46).
What is less understood is the response of MSNA to long-
lasting pain, which considering the clinical significance of chronic 
pain is more relevant and important to our understanding. The 
pain induced by bolus intramuscular or subcutaneous injec-
tions of hypertonic saline lasts only ~8 min, which is only long 
enough to study the acute effects of pain. In order to investigate 
the physiological consequences of long-term pain on cardio-
vascular regulation in healthy human volunteers, we decided to 
infuse hypertonic saline into the tibialis anterior muscle over 
~45 min, which causes a deep dull ache – which often refers into 
the foot – that lasts about an hour. This is three times as long as 
that studied previously, in which an infusion of 20 min has been 
suggested to be a good clinical model for chronic muscle pain 
(47). We do not agree with this, but at the very least the approach 
may allow one to understand some of the initial physiological 
processes during the development of chronic pain. In our studies, 
we keep the pain at a constant level by adjusting the rate of infu-
sion; subjects experienced a steady-state level of pain (tonic pain) 
rated 5–6/10 on a numerical rating scale (NRS).
Interestingly, using this experimental model of tonic muscle 
pain, we showed that MSNA displayed two types of responses 
(Figure 1). Here, the proportion of subjects showing decreases 
in MSNA was greater in response to the long-lasting noxious 
stimulus than that we had observed following bolus injections. 
It would appear that these observations more closely support 
those reported by Lewis (26) where he noted “quiescence” or 
falls in BP in response to pain originating in deep structures. 
In about half of the subjects, MSNA burst amplitude increased, 
with parallel increases in BP, and HR (36). The other half of the 
subjects showed a decrease in MSNA, BP, and HR. Representative 
experimental records from these two contrasting responses are 
shown in Figure 2. These changes in MSNA matched the pain 
profile, beginning ~5 min after the start of the infusion of hyper-
tonic saline and being maintained throughout the period of tonic 
muscle pain. Observing these parallel changes for the entire dura-
tion reveals that the sympathetic and cardiovascular responses 
are maintained by ongoing noxious stimulation. Moreover, the 
data suggest that the increase in MSNA was driving the increase 
in BP, which has been typically observed with essential hyperten-
sion (48–50). In some subjects, however, MSNA decreased but 
they still demonstrated an increase in BP during the pain. It is 
likely that in these subjects the fall in MSNA was caused by a 
baroreflex-mediated increase in BP. Conversely, a reduction in 
both BP and MSNA could be the result of a nociceptor-driven 
withdrawal of MSNA.
Heart rate variability (HRV) is an often over-interpreted physi-
ological marker purportedly reflecting the relative contributions 
of sympathetic and parasympathetic (vagal) outflow to cardiac 
control (51). Spectral decomposition of the ECG reveals two 
primary bands: the high-frequency (HF) domain and the low-
frequency (LF) domain. The HF band (0.15–0.4 Hz) reflects vagal 
cardiac control (52), while the LF band (0.04–0.15 Hz) has been 
suggested to represent (primarily) sympathetic cardiac activa-
tion (53). However, evidence supporting the cardiac sympathetic 
origin of the LF component is not very strong, and recent work 
suggests that the LF band does not reflect cardiac sympathetic 
outflow per se but simply modulation of cardiac autonomic drive 
via the baroreflexes (54). In our first tonic, pain study differences 
in baseline HRV data suggested that the increasing MSNA group 
had a greater LF power at baseline and during pain assessed at 
three separate time intervals (36). However, when the study was 
expanded to include a larger number of participants (n = 50) this 
was shown not to hold, and there was no difference between any 
HRV parameters when comparing the increasing or decreasing 
group (55).
Given that the level of MSNA is consistent in a given individual 
on a day-to-day basis (56), we predicted that the pattern of sym-
pathetic response to tonic muscle pain would be identical across 
time. This was born out in a second study, in which we repeated 
the experiments in the same individuals after 3–27 weeks. In the 
majority of subjects, there was a consistent change in the direc-
tion of MSNA (Figure 3), which either increased in both sessions 
or decreased in both sessions; the changes in BP and HR were 
also the same in both recording sessions (38). We reasoned that 
these consistent changes infer that there are inherent character-
istics of an individual that could potentially predict whether they 
would increase or decrease in MSNA during long-lasting pain. 
However, in a large study of 50 subjects, we found no differences 
in baseline levels of MSNA, BP, HR, HRV, age, or body-mass 
index that could account for these differences (55).
FiGURe 1 | Tonic muscle pain caused a dichotomy of responses in muscle sympathetic nerve activity (MSNA) (A), mean blood pressure (B), and 
heart rate (C). Subjects were divided into two groups: some who showed excitatory responses to muscle pain (solid black symbols) and others who showed 
depressed activity (open symbols) (36).
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Gender was an important factor to consider, given that it has 
been shown that sex differences exist in certain aspects of cardio-
vascular control. For instance, while the control and sensitivity 
of the sympathetic baroreflex is comparable in both young men 
and women (57–59), it is known that that the increases in MSNA 
in response to head-up tilt differ between males and females 
(60). However, we showed that there was no effect of gender, as 
assessed in 25 males and 25 females: there was no difference in the 
FiGURe 2 | Representative increases in neural and effector-organ responses (A,B) and decreases (C,D) in different subjects in response to tonic 
muscle pain. Activity from one subject prior to tonic muscle pain (A) and 20 min post infusion (B) (ECG, electrocardiogram; BP, blood pressure; RMS, root mean 
square). MSNA from the common peroneal nerve shows little spontaneous activity pre-infusion (A). Note the increases in burst frequency, burst amplitude, and BP 
during infusion of hypertonic saline (B). By contrast, note the reduction of MSNA in another subject who showed reductions in MSNA burst frequency, burst 
amplitude, and BP when comparing baseline (C) to 13 min post infusion (D) [taken from Ref. (38)].
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FiGURe 3 | Changes in mean MSNA burst amplitude (A,B) and mean blood pressure (C,D) during tonic muscle pain induced by intramuscular 
infusion of hypertonic saline for two subjects (A,C) and (B,D) during two separate recording sessions (open and closed symbols). The subject 
illustrated on the left (A,C) exhibited a sustained increase in MSNA and BP during the course of infusion, while the subject illustrated on the right (B,D) showed a 
decrease. For both subjects, the direction of the changes was the same in both recording sessions [taken from Ref. (38)].
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propensity of males or females to exhibit an increase or decrease 
in MSNA during tonic muscle pain (55).
Given that a threatening stimulus, such as a strong noxious 
stimulus, would be expected to increase sympathetic outflow to 
many tissues as part of the fight or flight response, we speculated 
that subjects showing higher anxiety levels would show increases 
in MSNA during tonic muscle pain, while those who are better able 
to cope show decreases. However, in a recent psychometric study 
of 66 subjects, we showed that there were no differences in anxiety 
scores, assessed by the State and Trait Inventory, in the group of 
subjects in whom MSNA increased during tonic muscle pain and 
the group in whom MSNA decreased (61). Moreover, there were 
no differences in attitudes to pain between the two groups, as 
assessed using the Vigilance and Awareness Questionnaire, the 
Pain Anxiety Symptoms Scale, and the Pain Catastrophizing Scale 
(61). So, given the absence of baseline physiological or psycho-
logical differences between the two groups of subjects, we still 
do not know why there are two patterns of sympathetic response 
during tonic muscle pain.
Skin Sympathetic Nerve Activity
Specific work regarding the influence of mental or emotional 
stress on skin sympathetic nerve activity (SSNA) is sparse (62). 
It would appear from the literature that the majority of studies 
examining the relationship between painful stimuli and SSNA 
have largely been used for the purpose of identifying SSNA 
(63–65). Depending on the duration of the painful stimulus, our 
group found distinct responses when examining the change in 
SSNA over time. However, unlike the general sustained responses 
seen in MSNA, the increases in SSNA were brief and occurred 
irrespective of whether the source of the pain was muscle or 
skin. Figure 4 shows that transient increases in SSNA occurred 
irrespective of whether the noxious stimuli were short-lasting 
(~4–5 min) bolus injections of hypertonic saline (29) or 45-min 
infusions in which pain lasted about an hour (37). The noteworthy 
difference between bolus injections and infusions is that the latter 
exhibited a biphasic response: a prolonged decrease in SSNA (and 
increase in skin blood flow), which followed the initial surge in 
SSNA (and resultant decrease in skin blood flow and increases in 
sweat release).
Skin sympathetic nerve activity showed a transient increase in 
activity around the onset of pain (29). Since the painful stimuli 
lasted much longer than these transient neural and effector-organ 
responses, it is highly likely that cardiac and skin autonomic 
responses are related to the initial onset and sudden surge in pain 
level, essentially reflecting an arousal or alerting response. The 
concept of nociception acting as an arousal stimulus is supported 
by the fact that the increase in SSNA occurred slightly before the 
FiGURe 4 | Skin sympathetic nerve activity increased around the onset of pain for both bolus injections of hypertonic saline (A) and infusions (B). 
Note the biphasic response seen in B in response to tonic muscle pain: a prolonged decrease in SSNA following an initial surge in activity (i), with resultant changes 
in skin blood flow (ii), and vascular conductance (iii). This biphasic response is presumably related to the arousal component of pain, characterized by an increase in 
SSNA with concomitant decreases in skin blood flow followed by decreases in SSNA and increased skin blood flow [modified from Ref. (29, 37)].
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subjective onset of pain. This suggests that the neural response 
to a noxious stimulus is associated with a transient change in 
homeostasis – a transition from no pain to that of pain. Unlike 
animal studies, it remains unclear whether cutaneous vasocon-
strictor neurones in humans are reflexly inhibited during noxious 
stimulation of the skin (66), and whether the biphasic response to 
tonic muscle pain merely involves passive withdrawal of activity 
following the initial increase (37). As noted above, the fact that 
there were no signs of sympathetic activation (e.g., cutaneous 
vasoconstriction or sweat release) in individuals with spinal cord 
injury, who could not feel a painful stimulus delivered to their 
paralyzed legs, supports our conclusion that the initial increase 
in SSNA depends on the integrity of supraspinal pathways (46). 
In other words, the increase in SSNA reflects an affective response 
to the perception of a painful stimulus.
GeNeRAL DiSCUSSiON OF FiNDiNGS
Our studies have also raised other questions, which invite further 
investigation. One novel finding in the Burton et al. (29) study 
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is that the direction of skin blood flow responses to nociception 
depended on gender, with males exhibiting decreases in skin blood 
flow and females showing increases. Cooke et al. (67) found that 
mental arithmetic and deep inspiration, maneuvers that causes 
increases in cutaneous sympathetic outflow, caused reductions 
in hand and skin blood flow in men but increases in women (67, 
68). Cooke et  al. (67) further demonstrated that the responses 
to mental arithmetic were dependent on the prevailing level of 
sympathetic tone to resistance vessels by using whole-body heat-
ing or cooling to increase or decrease central sympathetic outflow 
to the hand (68). These effects are comparable to our findings, 
where we demonstrated for the first time that gender may play a 
role in determining how skin blood flow changes following acute 
noxious stimulation. However, studying skin blood flow changes 
during long-lasting muscle pain did not show any such difference 
between genders.
It is evident from our studies that certain subjects will show 
increases in MSNA during intramuscular infusion of hypertonic 
saline that are sustained as long as the painful stimulus is main-
tained. Given that a proportion of post-surgical patients will go 
on to develop chronic pain while others do not (69), this raises 
interesting questions about how certain patients recover and 
others have ongoing pain even when tissue healing has clearly 
taken place. Keay and Bandler (70) discuss the idea of pain being 
categorized into escapable and inescapable. Since noxious events 
signal the necessity to take action (71), once nociceptors are 
stimulated and signals are received at the cortex, higher sensory 
processing determines the level of threat, evoking an appropri-
ate integrated response. Logically speaking, pain originating in 
deeper structures would be inescapable, and pain originating 
from superficial structures would be escapable.
It is intriguing then to see a dichotomy of responses to 
intramuscular infusion, a method of nociceptor stimulation in 
deep tissues, that half of our subjects consistently responding 
with increasing sympathetic drive, which aligns more with the 
response typically associated with escapable pain. This finding is 
bizarre, on the one hand, yet exciting, on the other, as it could be 
a predictor of a subgroup of patients who may potentially develop 
chronic pain after sustaining injury due to the contribution of 
sustained increases in sympathetic drive.
It is plausible that the evoked response and changes in sym-
pathetic drive, which we have demonstrated, outlast the noxious 
input and may contribute to the development of chronic pain and 
associated cardiovascular comorbidities. These series of experi-
ments are in no way designed to definitively answer questions on 
the development of chronic pain. However, they certainly provide 
insightful evidence into the cardiovascular consequences of long-
lasting pain.
iMPLiCATiONS
Unlike the short-lasting pain we had previously induced by bolus 
injections (28, 29), we believe the physiological responses to tonic 
pain will more closely replicate episodes during which chronic 
pain patients are suffering and coping with their pain. Indeed, 
persistent deep pain is characterized by a passive coping response 
(70) and tonic muscle pain lasting only 20  min has been used 
as a model for chronic musculoskeletal pain. This method of 
inducing muscle pain offers the advantage of allowing a controlled 
investigation into how pain may modulate MSNA, BP, and HR. 
Conversely – assuming everything else is equal – one would need 
to know the level of MSNA in a person prior to the development of 
chronic pain in order to interpret any changes in muscle sympa-
thetic outflow. There is only one study to have reported changes 
in sympathetic nerve activity during chronic pain: in a single 
patient with chronic regional pain syndrome (CRPS), suspected 
to be sympathetically maintained because of the marked cutane-
ous vasoconstriction, there was no difference in sympathetic 
outflow to the painful limb compared to the contralateral non-
painful limb (35). Perhaps this is because both limbs were affected 
equally  –  in most instances, sympathetic outflow is distributed 
symmetrically to the left and right limbs. We postulate that a 
person who consistently exhibited increases in MSNA, BP, and 
HR during experimental muscle pain may – if he or she developed 
chronic pain from an injury in the future – go on to develop high 
BP. Interestingly, in a retrospective study, Bruehl et al. (69) showed 
that patients with post-surgical chronic pain have approximately 
twice the prevalence of clinical hypertension (39%) than patients 
without pain (21%). Why this should be is not known.
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